VoxNeuro’s Cognitive Health Assessments™ will be used alongside blood tests and various behavioural and clinical assessments to identify biomarkers of bipolar disorder.

VBI Vaccines, a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, has reported that the Phase 3 study of its trivalent hepatitis B vaccine has met both primary and secondary endpoints for safety and efficacy.

The Trade Commissioner Service is currently recruiting for the Canadian Technology Accelerator cohort for life sciences start-ups and companies seeking to expand in the US and Asia.

Toronto-based Deep Genomics, which has developed a platform that uses deep learning to create therapies, has closed a $40 million Series B round.

ProteinQure, which has designed a platform to automate the computational design of protein-based drugs, has been named one of CB Insights’ Game Changers for 2020.

Synaptive Medical, a Toronto-based medical and technology company solving surgical, imaging and data challenges, has completed a first round of investment totaling $25,000,000 USD.

Flosonics Medical, founded in February 2015, is focused on making a wearable ultrasound monitor to help clinicians with precision fluid management.

Bright Angel Therapeutics, a biotechnology company focused on developing novel antifungal drugs, today announced an extension to their seed financing round, adding funding that will enable continued advancement of their lead program targeting invasive and drug-resistant fungal infections.

Marion Surgical, which is building the world's first Virtual Reality Surgical Simulator, is one of the companies selected by the Canadian Digital Media Network, to join its Soft Landing program.

RetiSpec was selected as the winner of iGan Partners’ annual Pitch to Heal Event.

Canadian manufacturer KA Imaging has managed to overcome the challenge of having soft-tissue differentiation and single exposure featured in the same digital X-ray detector. The company plans to present Reveal™ to the Health Care market next year. Reveal™ is the world’s first portable digital detector capable of separating different energy levels.

Winterlight Labs Inc., a company that is developing a proprietary AI technology to identify possible cognitive or functional changes in patients, has raised $5.6 million in new funding. The funding round was led by Hikma Ventures.

NERv Technology, a medical technology start-up co-founded by two University of Waterloo engineering alumni, topped more than 100,000 applicants to take first place and the $500,000 prize at the Entrepreneurship World Cup in Saudi Arabia.